泰格醫藥 (3347.HK)

33.950 -0.050 (-0.15%) 市場開市。 截至 09:46AM HKT。

泰格醫藥

Shengda Science Park
Building A, Floor 18 No.19 Jugong Road Binjiang District
Hangzhou 310051
China
86 571 2888 7227
https://www.tigermedgrp.com

版塊: Healthcare
行業: Diagnostics & Research
全職員工: 9,701

高階主管

名稱	頭銜	支付	行使價	出生年份
Dr. Xiaoping Ye D.Phil, EMBA, M.D., Ph.D.	Co-Founder & Chairman	1.38M	無	1963
Dr. Xiaochun Cao M.D.	Co-Founder, GM & Executive Director	1.32M	無	1969
Mr. Hao Wu	Co-President & Executive Director	4.07M	無	1967
Ms. Chengcheng Yang	Chief Financial Officer	無	無	1974
Mr. Zengyu Wen	Executive VP, COO & Executive Director	無	無	1980
Dr. Tianrong Ji M.D., Ph.D.	Chief Investment Officer	無	無	無
Mr. Guoyun Yu	Head of Accounting Department	無	無	無
Mr. Jiansong Yang Ph.D.	Senior VP & Chief Scientific Officer	無	無	無
Mr. Alan Liu	Chief Compliance Officer	無	無	無
Dr. Xiao Li Shi M.D.	VP & Head of Data Resources Department	無	無	1971

截止 2022年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

Hangzhou Tigermed Consulting Co., Ltd provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, clinical development strategy, site management, subject recruitment, medical device/ in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. It also provides product market research, product marketing strategy, product finalization, product verification, registration strategy planning, marketing application, post-marketing supports, and product upgrade services. In addition, the company offers medical imaging, pharmacovigilance, medical translation, quality assurance, GMP consulting, central laboratories, functional services, EDC system, and call center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and project management services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.

公司管治

截至 無 止，泰格醫藥 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。